Literature DB >> 22387545

Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids.

Christophe Morisseau1, Nils Helge Schebb, Hua Dong, Arzu Ulu, Pavel A Aronov, Bruce D Hammock.   

Abstract

The EPXH2 gene encodes for the soluble epoxide hydrolase (sEH), which has two distinct enzyme activities: epoxide hydrolase (Cterm-EH) and phosphatase (Nterm-phos). The Cterm-EH is involved in the metabolism of epoxides from arachidonic acid and other unsaturated fatty acids, endogenous chemical mediators that play important roles in blood pressure regulation, cell growth, inflammation and pain. While recent findings suggested complementary biological roles for Nterm-phos, its mode of action is not well understood. Herein, we demonstrate that lysophosphatidic acids are excellent substrates for Nterm-phos. We also showed that sEH phosphatase activity represents a significant (20-60%) part of LPA cellular hydrolysis, especially in the cytosol. This possible role of sEH on LPA hydrolysis could explain some of the biology previously associated with the Nterm-phos. These findings also underline possible cellular mechanisms by which both activities of sEH (EH and phosphatase) may have complementary or opposite roles.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22387545      PMCID: PMC3313618          DOI: 10.1016/j.bbrc.2012.02.108

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

Review 1.  Targeting epoxides for organ damage in hypertension.

Authors:  John D Imig
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

Review 2.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

Review 3.  Inflammatory lipid mediators in adipocyte function and obesity.

Authors:  Abishek Iyer; David P Fairlie; Johannes B Prins; Bruce D Hammock; Lindsay Brown
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

4.  Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis.

Authors:  Pengcheng Luo; Hsin-Hsin Chang; Yiqiang Zhou; Shali Zhang; Sung Hee Hwang; Christophe Morisseau; Cong-Yi Wang; Edward W Inscho; Bruce D Hammock; Mong-Heng Wang
Journal:  J Pharmacol Exp Ther       Date:  2010-05-03       Impact factor: 4.030

5.  Characterization of the human LPIN1-encoded phosphatidate phosphatase isoforms.

Authors:  Gil-Soo Han; George M Carman
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

6.  Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth.

Authors:  Ami Oguro; Koichi Sakamoto; Sachiko Suzuki; Susumu Imaoka
Journal:  Biol Pharm Bull       Date:  2009-12       Impact factor: 2.233

7.  Expression and regulation of soluble epoxide hydrolase in adipose tissue.

Authors:  Bart M De Taeye; Christophe Morisseau; Julie Coyle; Joseph W Covington; Ayala Luria; Jun Yang; Sheila B Murphy; David B Friedman; Bruce B Hammock; Douglas E Vaughan
Journal:  Obesity (Silver Spring)       Date:  2009-07-30       Impact factor: 5.002

8.  Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.

Authors:  Cristiano Fava; Martina Montagnana; Elisa Danese; Peter Almgren; Bo Hedblad; Gunnar Engström; Göran Berglund; Pietro Minuz; Olle Melander
Journal:  Pharmacogenet Genomics       Date:  2010-02       Impact factor: 2.089

Review 9.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

Review 10.  Epoxyeicosanoid signaling in CNS function and disease.

Authors:  Jeffrey J Iliff; Jia Jia; Jonathan Nelson; Toru Goyagi; Judy Klaus; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-06-21       Impact factor: 3.072

View more
  23 in total

1.  Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.

Authors:  Naoki Matsumoto; Eriko Suzuki; Makoto Ishikawa; Takumi Shirafuji; Keiji Hasumi
Journal:  J Biol Chem       Date:  2014-10-31       Impact factor: 5.157

Review 2.  Role of epoxide hydrolases in lipid metabolism.

Authors:  Christophe Morisseau
Journal:  Biochimie       Date:  2012-06-18       Impact factor: 4.079

3.  Reconfigurable microfluidic dilution for high-throughput quantitative assays.

Authors:  Jinzhen Fan; Baoqing Li; Siyuan Xing; Tingrui Pan
Journal:  Lab Chip       Date:  2015-06-21       Impact factor: 6.799

Review 4.  Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health.

Authors:  Christophe Morisseau; Bruce D Hammock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

5.  Structure-activity relationships of the plasminogen modulator SMTP with respect to the inhibition of soluble epoxide hydrolase.

Authors:  Naoki Matsumoto; Eriko Suzuki; Kota Tsujihara; Yuuichi Nishimura; Keiji Hasumi
Journal:  J Antibiot (Tokyo)       Date:  2015-05-13       Impact factor: 2.649

6.  Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation.

Authors:  Christophe Morisseau; Aaron T Wecksler; Catherine Deng; Hua Dong; Jun Yang; Kin Sing S Lee; Sean D Kodani; Bruce D Hammock
Journal:  J Lipid Res       Date:  2014-04-27       Impact factor: 5.922

7.  Endocervical and Neutrophil Lipoxygenases Coordinate Neutrophil Transepithelial Migration to Neisseria gonorrhoeae.

Authors:  Jacqueline S Stevens; Mary C Gray; Christophe Morisseau; Alison K Criss
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

8.  Development of an HTS assay for EPHX2 phosphatase activity and screening of nontargeted libraries.

Authors:  Christophe Morisseau; Sunil Sahdeo; Gino Cortopassi; Bruce D Hammock
Journal:  Anal Biochem       Date:  2012-12-03       Impact factor: 3.365

9.  Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.

Authors:  Christophe Morisseau; Svitlana Pakhomova; Sung Hee Hwang; Marcia E Newcomer; Bruce D Hammock
Journal:  Bioorg Med Chem Lett       Date:  2013-05-06       Impact factor: 2.823

10.  Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.

Authors:  Kenneth I Strauss; Artiom Gruzdev; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-08-16       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.